Efficacy of intravenous pulse cyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyclophosphamide treatment in steroid-resistant nephrotic syndrome

Pediatric Nephrology

Volumn 23, Issue 9, 2008, Pages 1495-1502

  Mantan, Mukta ^a   Sriram, Chenni S ^b   Hari, Pankaj ^b   Dinda, Amit ^b   Bagga, Arvind ^b  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Focal segmental glomerulosclerosis; Minimal change disease; Steroid resistant nephrotic syndrome

Indexed keywords

ANTILIPEMIC AGENT; CALCIUM CARBONATE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ENALAPRIL; FUROSEMIDE; MESNA; ONDANSETRON; PREDNISOLONE; STEROID;

ABDOMINAL OBESITY; ADOLESCENT; ADULT; ALOPECIA; ARTICLE; BRAIN DISEASE; CELLULITIS; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUSHINGOID SYNDROME; DRUG DOSAGE FORM COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG WITHDRAWAL; EDEMA; ELECTROLYTE DISTURBANCE; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; HEART ARRHYTHMIA; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOKALEMIA; IDIOPATHIC DISEASE; INFECTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MENINGITIS; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SEIZURE; SEPSIS; SINGLE DRUG DOSE; SKIN TOXICITY; SUBCAPSULAR CATARACT; TREATMENT DURATION; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; LOGISTIC MODELS; MALE; NEPHROTIC SYNDROME;

EID: 47749089689     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0860-8     Document Type: Article

References (28)

1. Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629-639
2. Niaudet P, Fuchshuber A, Gagnadoux MF, Habib R, Broyer M (1997) Cyclosporine in the therapy of steroid-resistant idiopathic nephrotic syndrome. Kidney Int Suppl 58:S85-S90
3. Habashy D, Hodson EM, Craig JC (2003) Interventions for steroid-resistant nephrotic syndrome: A systematic review. Pediatr Nephrol 18:906-912
4. Bhimma R, Adhikari M, Asharam K, Connolly C (2006) Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus. Am J Nephrol 26:544-551
5. Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA (1995) Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: A long-term follow-up. Clin Nephrol 43:84-88
6. Tune BM, Lieberman E, Mendoza SA (1996) Steroid resistant focal segmental glomerulosclerosis; a treatable disease. Pediatr Nephrol 10:772-778
7. Rennert WP, Kala UK, Jacobs D, Goetsch S, Verhaart S (1999) Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis. Pediatr Nephrol 13:113-116
8. Gulati S, Kher V (2000) Intravenous pulse cyclophosphamide - a new regime for steroid resistant focal segmental glomerulosclerosis. Indian Pediatr 37:141-148
9. Hari P, Bagga A, Jindal N, Srivastava RN (2001) Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide. Pediatr Nephrol 16:901-905
10. Hari P, Bagga A, Mantan M (2004) Short term efficacy of intravenous dexamethasone and methylprednisolone therapy in steroid resistant nephrotic syndrome. Indian Pediatr 41:993-1000
11. Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN (2003) Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome. Pediatr Nephrol 18:351-356
12. Schwartz GJ, Haycock GB, Edelman CM, Spitzer A (1976) A simple measure of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259-263
13. Indian Pediatric Nephrology Group, Indian Academy of Pediatrics (2001) Consensus statement on management of steroid sensitive nephrotic syndrome. Indian Pediatr 38:975-986
14. National Center for Health Statistics (1978) Centers for Disease Control NCHS growth curves for children: Birth-18 years. Washington DC: US Government Printing Office (Series 11, 165. DHEW publication (PHS) 78 1650)
15. Adhikari M, Bhimma R, Coovadia HM (1997) Intensive pulse therapies for focal glomerulosclerosis in South African children. Pediatr Nephrol 11:423-8
16. Elhence R, Gulati S, Kher V, Gupta A, Sharma RK (1994) Intravenous pulse cyclophosphamide - a new regime for steroid resistant minimal change nephrotic syndrome. Pediatr Nephrol 8:1-3
17. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769-776
18. Tarshish P, Tobin JN, Bernstein J, Edelman CM Jr (1996) Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis: A report of the International Study of Kidney Diseases in Children. Pediatr Nephrol 10:590-593
19. Bhimma R, Adhikari M, Asharam K (2006) Steroid-resistant nephrotic syndrome: The influence of race on cyclophosphamide sensitivity. Pediatr Nephrol 21:1847-1853
20. Ingulli E, Tejani A (1991) Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 5:393-397
21. Boyer O, Moulder JK, Somers MJG (2007) Focal and segmental glomerulosclerosis in children: A longitudinal assessment. Pediatr Nephrol 22:1159-1166
22. Gulati S, Kher V, Sharma RK, Gupta A (1994) Steroid response pattern in Indian children with nephrotic syndrome. Acta Paediatr 83:530-533
23. Mongeau JG, Corneille L, Robitaille P, O'Regan S, Pelletier P (1981) Primary nephrosis in childhood associated with focal segmental glomerulosclerosis: Is long term prognosis that severe? Kidney Int 20:743-746
24. Hiraoka M, Tsukahara H, Haruki S, Hayashi S, Takeda N, Miyagawa K, Okuhara K, Suehiro F, Ohshima Y, Mayumi M (2000) Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome The West Japan Cooperative Study of Kidney Disease in Children. Kidney Int 58:1247-1252
25. Constantinescu AR, Shah HB, Foote EF, Weiss LS (2000) Predicting first year relapses in children with nephrotic syndrome. Pediatrics 105:492-495
26. Latta K, Von Schnakenburg C, Ehrich JH (2001) A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 16:271-282
27. Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, Ponticelli C, Saito T, Choukroun G, Nachman P, Praga M, Yoshikawa N (2007) Cyclosporine in idiopathic glomerular disease associated with the nephritic syndrome: Workshop recommendations. Kidney Int 72:1429-1447
28. Gulati S, Prasad N, Sharma RK, Kumar A, Gupta A, Baburaj VP (2008) Tacrolimus: A new therapy for steroid resistant nephrotic syndrome in children. Nephrol Dial Transplant 23:910-913